Regulatory news

Contact investor relations

Institutional investors

Please contact David Bishop or Reece de Gruchy, our Investor Relations team by email at investor.relations@croda.com.

Individual investors

Our registrars, Link Asset Services, are here to help with queries from individual investors. Please contact them directly on +44 (0)371 664 0300 (calls are charged at the standard geographic rate and will vary by provider).

You can also sign up to the Registrar's website - www.signalshares.com - you will need your investor code to do this and once registered you will be able to check your shareholding, view your dividend history, elect for the dividend reinvestment plan, register a change of address and update dividend mandate instructions.

Mailing list

If you would like to receive investor relations information via email please provide your details below.

Please provide your first name
Please provide your last name
Email is not valid
Please select your country

Interest

Please select at least one
We need your consent
Please tick reCaptcha.

Read more

this needs to be updated when we get a new image

Croda commissions Guangzhou Hub to strengthen strategic growth and innovation in China

26 June 2026: Croda opens new Guangzhou hub, bringing together fragrance and beauty actives expertise to enhance customer collaboration and innovation across Asia.
lady smiling with flowing fabric behind her

Croda strengthens premium beauty pipeline with next-generation skincare active Malvallin™

17 June 2026: Croda launches Malvallin™, a patent‑pending botanical active that supports skin firmness, hydration and resilience, meeting growing demand for preventative, premium skincare solutions.
Medical scientist analysing test tube

Croda expands advanced drug delivery capabilities through NovoArc collaboration

15 June 2026: Croda expands advanced drug delivery capabilities through collaboration with NovoArc, enhancing lipid technologies for more stable and flexible therapeutic delivery.